Zobrazeno 1 - 10
of 14
pro vyhledávání: '"T. K. Held"'
Autor:
Andrew J. Ullmann, J. Gmür, Emilio Paolo Alessandrino, J. Pretnar, Plínio Trabasso, Per Ljungman, Simona Sica, Catherine Cordonnier, T. K. Held, R. Varela, K. Fabian, Hamdi Akan, Montserrat Rovira, Antonin Vitek, N. Wulffraat, M. S. Ward, Rodrigo Martino
Publikováno v:
Clinical Infectious Diseases. 38:1229-1236
The Infectious Diseases Working Party of the European Blood and Marrow Transplant Group conducted a survey to obtain information about the frequency, presentation, and treatment of mycobacterial infection (MBI) in stem cell transplant (SCT) recipient
Autor:
O Oswald, Andreas Nitsche, T. K. Held, J Oertel, Johannes Schetelig, Stefanie Thulke, Wolfgang Siegert, N Steuer, Aleksandar Radonic
Publikováno v:
Bone Marrow Transplantation. 32:695-701
Since the incidence of cytomegalovirus (CMV) infections after hematopoietic stem cell transplantation (HSCT) may depend on the intensity of the pretreatment, we studied the incidence of CMV infections after reduced-intensity compared to myeloablative
Publikováno v:
Intensive Care Medicine. 28:824-833
Antibiotic-induced release of bacterial cell wall components can have immediate adverse effects for the patient. This article reviews the data on endotoxin release after initiation of antibiotic therapy and its role in the pathogenesis of sepsis and
Autor:
Stefan S. Biel, Andreas Kurth, T. K. Held, Andreas Nitsche, Wolfgang Siegert, Hans R. Gelderblom, S Chen
Publikováno v:
Bone Marrow Transplantation. 26:347-350
Hemorrhagic cystitis (HC) is a common complication following high-dose chemotherapy and bone marrow transplantation, and the treatment of virus-associated HC remains to be optimized. This is the first report on the successful use of cidofovir in a pa
Autor:
Andrew J. Ullmann, Stéphane Bretagne, J Maertens, Catherine Cordonnier, Montserrat Rovira, Eric Deconinck, T. K. Held, Rodrigo Martino
Publikováno v:
Bone Marrow Transplantation. 25:1111-1114
Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Publikováno v:
Der Internist. 51(7)
The production of hematopoietic cells is under the tight control of distinct growth factors. As therapeutic agents, granulocyte colony-stimulating factor (G-CSF), erythropoietin (EPO), and thrombopoiesis-stimulating agents (TSA) are in routine clinic
Publikováno v:
Pneumologie. 58
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 7(3)
Objective A new quantitative polymerase chain reaction (real-time PCR) was designed to detect Toxoplasma DNA in human body fluid samples. Methods Real-time fluorescence detection of amplification product formation on the basis of the TaqMan-System wa
Autor:
Andrew J. Ullmann, Eric Deconinck, Catherine Cordonnier, T. K. Held, J Maertens, Montserrat Rovira, Rodrigo Martino, Stéphane Bretagne
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 31(5)
In immunocompromised individuals, toxoplasmosis mostly occurs as a reactivation of a latent infection, causing severe to life-threatening disease. Thus, recipients who are seropositive for Toxoplasma gondii before an allogeneic hematopoietic stem cel
Publikováno v:
Blood. 91(7)
Besides its well-established effects on granulocytopoiesis, granulocyte colony-stimulating factor (G-CSF) has been shown to have direct effects on the recruitment and bactericidal ability of neutrophils, resulting in improved survival of experimental